Global Sleep Apnea Devices Market Trends, Forecast Report 2025-2037
Sleep Apnea Devices Market size is expected to grow from USD 10.38 billion to USD 25.51 billion, registering a CAGR of more than 7.1% during the forecast timeline, between 2025 and 2037. In the year 2025, the industry size of sleep apnea devices is estimated at USD 10.98 billion.
Market growth is primarily driven by increased prevalence of chronic conditions which is expected to increase the load of OSA. Comorbidities such as diabetes, hypertension, cardiovascular diseases, and obesity are commonly associated with OSA. According to World Health Organization, globally, around 17.9 million people cave in to death to cardiovascular problem.
Sleep Apnea is a sleeping disorder in which the patient faces, pauses in breathing or periods of shallow breathing during sleep occur more often than normal, and it can happen numbers of time in a night. Without treatment, sleep apnea may increase the risk of heart attack, stroke, diabetes, heart failure, irregular heartbeat, and obesity. According to World Health Organization, more than 1 billion people worldwide are obese - 650 million adults, 340 million adolescents and 39 million children.
Sleep Apnea Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Demand for Home Sleep Apnea Tests – According to data from the American Sleep Association, nearly 50 million to 70 million U.S. adults have a sleep disorders, of which, 25 million are suffering from obstructive sleep apnea.
- Rising Prevalence of Obesity to Increase Diagnosis Rate for Sleep Apnea – According to the article published by American Heart Association, Inc., several cross-sectional studies have estimated that significant sleep apnea is present in 40% of the obese population, and 70% of the OSA patients are obese.
- Advanced Innovation in Technology for Sleep Apnea Devices - As per the data by the World Bank, 2.33% of the global GDP was spent on research and development activities in 2019, which increased to 2.63% in 2020.
- Increasing Access to Health Care and Health Expenditures- As per the data by the World Bank, 9.83% of the global GDP was spent on health expenditure in 2019.
Challenges
- High Cost of Devices and Long Waiting Periods
- Lack of Patient Compliance to Device Therapies
Sleep Apnea Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.1% |
|
Base Year Market Size (2024) |
USD 10.38 billion |
|
Forecast Year Market Size (2037) |
USD 25.51 billion |
|
Regional Scope |
|
Sleep Apnea Devices Segmentation
Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks)
The sleep apnea masks are anticipated to hold the largest sleep apnea devices market size by the end of 2037. The segment growth is primarily attributed to rising prevalence of comorbidities associated with obstructive sleep apnea (OSA), and rising adoption rates of CPAP machines in disease management. As per research, it is estimated that 936 million adults aged 30-69 years (men and women) have mild to moderate obstructive sleep apnea and over 425 million adults aged 30-69 years have moderate to severe obstructive sleep apnea globally.
Our in-depth analysis of the global market includes the following segments:
|
By Disease Type |
|
|
By Product Type |
|
|
By Patient Demographics |
|
|
By End User |
|
|
By Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportSleep Apnea Devices Industry - Regional Synopsis
Asia Pacific is projected to hold largest market share by the end of 2037, owing to growing geriatric population and rising prevalence of diseases such as cardiovascular diseases, cancer, hypertension, and diabetes. According to International Diabetes Federation (IDF), in 2021, 90 million adults were diagnosed with diabetes in South-East Asia region.
Companies Dominating the Sleep Apnea Devices Market
- Philips Respironics
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BMC Medical Co. ltd.
- Curative Medical Inc.
- SOMNOmedics GmbH
- Itamar Medical Ltd.
- Nihon Kohden Corporation
- ResMed INC.
- Natus Medical Incorporated
- Invacare Corporation
- Compumedics Limited.
In the News
- ResMed launches AirSense 11 PAP series, advancing digital health in sleep apnea treatment. New digital features designed to make therapy setup and nightly use easier for patients.
- Nihon Kohden announced the launch of POLYSMITH 12 polysomnography software, driven features that offer sleep specialists improved workflow, analysis and outcomes.
Author Credits: Radhika Pawar
- Report ID: 183
- Published Date: Jan 17, 2025
- Report Format: PDF, PPT
